Inhaled beclomethasone in the treatment of early COVID-19: a phase 2, double-blind, placebo-controlled, randomised trial

Clin Med (Lond). 2023 Nov;23(Suppl 6):66-68. doi: 10.7861/clinmed.23-6-s66.
No abstract available

Publication types

  • Randomized Controlled Trial
  • Clinical Trial, Phase II

MeSH terms

  • Beclomethasone* / therapeutic use
  • COVID-19*
  • Humans

Substances

  • Beclomethasone